Kazia Therapeutics (KZIA) Receivables - Other (2018 - 2025)

Kazia Therapeutics' Receivables - Other history spans 4 years, with the latest figure at $57639.0 for Q2 2025.

  • For Q2 2025, Receivables - Other changed N/A year-over-year to $57639.0; the TTM value through Jun 2025 reached $57639.0, changed N/A, while the annual FY2025 figure was $57639.0, N/A changed from the prior year.
  • Receivables - Other reached $57639.0 in Q2 2025 per KZIA's latest filing, down from $69509.5 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $69509.5 in Q2 2023 to a low of $28650.7 in Q2 2022.
  • Average Receivables - Other over 3 years is $51933.1, with a median of $57639.0 recorded in 2025.
  • The largest YoY upside for Receivables - Other was 142.61% in 2023 against a maximum downside of 142.61% in 2023.
  • A 3-year view of Receivables - Other shows it stood at $28650.7 in 2022, then soared by 142.61% to $69509.5 in 2023, then decreased by 17.08% to $57639.0 in 2025.
  • Per Business Quant, the three most recent readings for KZIA's Receivables - Other are $57639.0 (Q2 2025), $69509.5 (Q2 2023), and $28650.7 (Q2 2022).